Farydak (panobinostat capsules – Novartis) — Cigna
Multiple myeloma
Initial criteria
- Patient is currently receiving Farydak; AND
- Patient has previously tried bortezomib injection; AND
- Patient has tried one immunomodulatory drug (i.e., Thalomid [thalidomide capsules], lenalidomide capsules, or Pomalyst [pomalidomide capsules]); AND
- Medication will be taken in combination with bortezomib injection and dexamethasone
Approval duration
1 year